arrow
L

Limei Poon

national university cancer institute
H指数:14
被引数:1,088

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Deceased donor kidney transplantation in candidates with pre-transplant hematological malignancies: a literature review and recipient allocation proposal in Singapore

供者肾移植在移植前患有血液系统恶性肿瘤的候选者中的应用:新加坡的文献综述及受者分配方案

2025-08-220
OAAI
Impact of C-MYC/BCL2 Double Expression on Survival Outcomes After Autologous Transplantation in Relapsed/Refractory Diffuse Large B Cell Lymphoma-A Nationwide Retrospective Analysis in Singapore
2024-12-270
PRE
Machine Learning Classification of Spatial Patterns of Malignant Cells Reveals Implications in Prognosis and Tumor Microenvironment Composition in Lymphoma

机器学习对恶性细胞空间模式的分类揭示了其在淋巴瘤预后和肿瘤微环境组成方面的意义

BLOOD
IF23.1
2024-11-050
PRE
Fratricide-resistant CD7-CAR T cells in T-ALL

T-all中的抗自杀性CD7-CAR T细胞

2024-09-033
PRE
Single Cell Resolution Spatial Modeling Uncovers Survival-associated Phenotypes in Diffuse Large B Cell Lymphoma
2024-04-150
PRE
Patterns of Oncogene Coexpression at Single-Cell Resolution Influence Survival in Lymphoma
2023-04-182
OAAI
Patterns of oncogene co-expression at single cell resolution influence survival in diffuse large B-cell lymphoma
2023-04-040
PRE
An ex vivo platform to guide drug combination treatment in relapsed/refractory lymphoma
2022-10-1916
PRE
Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma (vol 34, 3413, 2020)
LEUKEMIA
IF13.4
2021-03-080
OAAI
Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma
LEUKEMIA
IF13.4
2020-08-0560
OAAI